Nightingale by Health Care Originals® is delighted to announce that we have raised $1,700,000 in our latest funding round—a milestone that marks an exciting new chapter in our journey to revolutionize respiratory care. Nearly 50 million Americans live with Asthma, COPD, or both, and our innovative platform stands as the first complete virtual respiratory care solution designed exclusively for these conditions. This significant influx of capital is set to accelerate our mission in providing accessible, comprehensive, and personalized care to those in need. With the funds raised, we are poised to enhance our cutting-edge telehealth infrastructure, expand our remote monitoring capabilities, and integrate advanced data analytics to better tailor management plans for respiratory patients. Our commitment is not only to improve day-to-day care but also to empower patients with the knowledge and tools they need to take control of their respiratory health in a virtual setting.
Moreover, this funding will enable us to broaden our outreach efforts, build strategic partnerships with leading healthcare providers, and invest in research and development to innovate even further in digital healthcare solutions. At a time when demand for effective, accessible respiratory care is critically high, Nightingale is proud to offer a platform that bridges the gap between traditional clinical practices and modern, virtual care delivery. We are excited about the opportunities ahead as we continue to transform the landscape of respiratory care, making high-quality, personalized treatment accessible to millions, all from the comfort of patients’ homes. This funding round is a strong vote of confidence in our vision to redefine respiratory care for a better, healthier future.
